Sio Gene Therapies Inc. SIOX
As ofFeb 7, 2024, 3:58 PM EST
SIOX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-61,041,000 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-03-31 | -61,041,000 | -14,054,000 | Not meaningful |
| FY 2021 | 2021-03-31 | -46,987,000 | 20,741,000 | Not meaningful |
| FY 2020 | 2020-03-31 | -67,728,000 | 66,681,000 | Not meaningful |
| FY 2019 | 2019-03-31 | -134,409,000 | 60,223,000 | Not meaningful |
| FY 2018 | 2018-03-31 | -194,632,000 | -82,418,000 | Not meaningful |
| FY 2017 | 2017-03-31 | -112,214,000 | -58,773,000 | Not meaningful |
| FY 2016 | 2016-03-31 | -53,441,000 | -52,749,380 | Not meaningful |
| FY 2015 | 2015-03-31 | -691,620 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.